Assignee
TRANSLATE BIO MA INC
US·19 granted patents·7 pending applications·98 citations·filing 2013–2025
Top patents by PatentIndex Score
26 records- 0198US9790494B2Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Oct 17, 2017·24 cites·20 claims
- 0293US10059941B2Compositions and methods for modulating SMN gene family expressionTRANSLATE BIO MA INC·Filed 2013·Granted Aug 28, 2018·13 cites·38 claims
- 0392US10174323B2Compositions and methods for modulating ATP2A2 expressionTRANSLATE BIO MA INC·Filed 2013·Granted Jan 8, 2019·11 cites·31 claims
- 0490US10174328B2Compositions and methods for treating amyotrophic lateral sclerosisTRANSLATE BIO MA INC·Filed 2014·Granted Jan 8, 2019·7 cites·45 claims
- 0589US9732340B2Multimeric oligonucleotides compounds having cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Aug 15, 2017·6 cites·18 claims
- 0689US9732341B2Methods of delivering multiple targeting oligonucleotides to a cell using cleavable linkersTRANSLATE BIO MA INC·Filed 2015·Granted Aug 15, 2017·6 cites·18 claims
- 0788US10093924B2Multimetric oligonucleotide compoundsTRANSLATE BIO MA INC·Filed 2017·Granted Oct 9, 2018·5 cites·22 claims
- 0886US10655128B2Compositions and methods for modulating MECP2 expressionTRANSLATE BIO MA INC·Filed 2017·Granted May 19, 2020·4 cites·16 claims
- 0983US10844375B2Multimeric oligonucleotide compounds having non-nucleotide based cleavable linkersTRANSLATE BIO MA INC·Filed 2017·Granted Nov 24, 2020·1 cites·20 claims
- 1083US10174315B2Compositions and methods for modulating hemoglobin gene family expressionTRANSLATE BIO MA INC·Filed 2013·Granted Jan 8, 2019·6 cites·31 claims
- 1182US10058623B2Compositions and methods for modulating UTRN expressionTRANSLATE BIO MA INC·Filed 2013·Granted Aug 28, 2018·5 cites·32 claims
- 1278US10041074B2Euchromatic region targeting methods for modulating gene expressionTRANSLATE BIO MA INC·Filed 2015·Granted Aug 7, 2018·7 cites·13 claims
- 1377US11253601B2Nucleic acid conjugates and uses thereofTRANSLATE BIO MA INC·Filed 2017·Granted Feb 22, 2022·2 cites·19 claims
- 1474US2025312422A1Compositions and methods for facilitating delivery of synthetic nucleic acids to cellsTRANSLATE BIO MA INC·Filed 2024·Application pending·0 cites
- 1566US12478682B2Nucleic acid conjugates and uses thereofTRANSLATE BIO MA INC·Filed 2021·Granted Nov 25, 2025·0 cites·18 claims
- 1666US10704046B2Multimeric oligonucleotide compoundsTRANSLATE BIO MA INC·Filed 2018·Granted Jul 7, 2020·0 cites·31 claims
- 1764US10758558B2Hybrid oligonucleotides and uses thereofTRANSLATE BIO MA INC·Filed 2016·Granted Sep 1, 2020·1 cites·20 claims
- 1863US2025360089A1Nanoparticle formulations for delivery of nucleic acid complexesTRANSLATE BIO MA INC·Filed 2025·Application pending·0 cites
- 1956US12178855B2Compositions and methods for facilitating delivery of synthetic nucleic acids to cellsTRANSLATE BIO MA INC·Filed 2019·Granted Dec 31, 2024·0 cites·21 claims
- 2054US12318489B2Nanoparticle formulations for delivery of nucleic acid complexesTRANSLATE BIO MA INC·Filed 2016·Granted Jun 3, 2025·0 cites·18 claims
- 2148US10837014B2Compositions and methods for modulating SMN gene family expressionTRANSLATE BIO MA INC·Filed 2018·Granted Nov 17, 2020·0 cites·32 claims
- 2247US2023062603A1Formulations for delivery of oligonucleotides to lung cellsTRANSLATE BIO MA INC·Filed 2021·Application pending·0 cites
- 2339US2018312839A1Methods and compositions for increasing smn expressionTRANSLATE BIO MA INC·Filed 2016·Application pending·0 cites
- 2434US2019055553A1Methods for identifying and targeting non-coding rna scaffoldsTRANSLATE BIO MA INC·Filed 2016·Application pending·0 cites
- 2532US2018055869A1Compositions and methods for modulating rnaTRANSLATE BIO MA INC·Filed 2016·Application pending·0 cites
- 2632US2018030452A1Targeting oligonucleotides and uses thereof to modulate gene expressionTRANSLATE BIO MA INC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when TRANSLATE BIO MA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →